Literature DB >> 18714015

B lymphocyte activation by coinfection prevents immune control of friend virus infection.

Rute Marques1, Inês Antunes, Urszula Eksmond, Jonathan Stoye, Kim Hasenkrug, George Kassiotis.   

Abstract

Although the adaptive immune response almost invariably fails to completely eliminate retroviral infections, it can exert significant protection from disease and long-term control of viral replication. Friend virus (FV), a mouse retrovirus, causes persistent infection in all strains of mice and erythroleukaemia in susceptible strains, the course of which can be strongly influenced by both genetic and extrinsic factors. In this study we examine the impact of coinfection on the requirements for immune control of FV infection. We show that congenic C57BL/6 mice, in which the introduction of an allele of the Friend virus susceptibility 2 gene provides the potential for FV-induced leukemia development, effectively resist FV infection, and both T cell- and Ab-dependent mechanisms contribute to their resistance. However, we further demonstrate that coinfection with lactate dehydrogenase-elevating virus (LDV) renders these otherwise immunocompetent mice highly susceptible to FV infection and subsequent disease. The presence of LDV delays induction of FV-specific neutralizing Abs and counteracts the protective contribution of adaptive immunity. Importantly, the disease-enhancing effect of LDV coinfection requires the presence of a polyclonal B cell repertoire and is reproduced by direct polyclonal B cell activation. Thus, immune activation by coinfecting pathogens or their products can contribute to the pathogenicity of retroviral infection.

Entities:  

Mesh:

Year:  2008        PMID: 18714015      PMCID: PMC2655735          DOI: 10.4049/jimmunol.181.5.3432

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  59 in total

1.  Kinetics of the development of protective immunity in mice vaccinated with a live attenuated retrovirus.

Authors:  U Dittmer; B Race; K J Hasenkrug
Journal:  J Virol       Date:  1999-10       Impact factor: 5.103

2.  Lactate dehydrogenase-elevating virus (LDV): lifelong coexistence of virus and LDV-specific immunity.

Authors:  M F van den Broek; R Spörri; C Even; P G Plagemann; E Hänseler; H Hengartner; R M Zinkernagel
Journal:  J Immunol       Date:  1997-08-15       Impact factor: 5.422

3.  Characterization of mouse monoclonal antibodies specific for Friend murine leukemia virus-induced erythroleukemia cells: friend-specific and FMR-specific antigens.

Authors:  B Chesebro; K Wehrly; M Cloyd; W Britt; J Portis; J Collins; J Nishio
Journal:  Virology       Date:  1981-07-15       Impact factor: 3.616

4.  Dual infection with HIV and malaria fuels the spread of both diseases in sub-Saharan Africa.

Authors:  Laith J Abu-Raddad; Padmaja Patnaik; James G Kublin
Journal:  Science       Date:  2006-12-08       Impact factor: 47.728

5.  Low-level CD4+ T cell activation is associated with low susceptibility to HIV-1 infection.

Authors:  Fransje A Koning; Sigrid A Otto; Mette D Hazenberg; Linda Dekker; Maria Prins; Frank Miedema; Hanneke Schuitemaker
Journal:  J Immunol       Date:  2005-11-01       Impact factor: 5.422

6.  Preinfection treatment of resistant mice with CpG oligodeoxynucleotides renders them susceptible to friend retrovirus-induced leukemia.

Authors:  Anke R M Olbrich; Simone Schimmer; Ulf Dittmer
Journal:  J Virol       Date:  2003-10       Impact factor: 5.103

7.  Infection of SCID mice with lactate dehydrogenase-elevating virus stimulates B-cell activation.

Authors:  D S Bradley; J J Broen; W A Cafruny
Journal:  Viral Immunol       Date:  1991       Impact factor: 2.257

8.  Persistent infection of mice by lactate dehydrogenase-elevating virus: effects of immunosuppression on virus replication and antiviral immune responses.

Authors:  C O Onyekaba; J T Harty; C Even; B G Hu; P G Plagemann
Journal:  Virus Res       Date:  1989-12       Impact factor: 3.303

9.  T-lymphocyte priming and protection against Friend leukemia by vaccinia-retrovirus env gene recombinant.

Authors:  P L Earl; B Moss; R P Morrison; K Wehrly; J Nishio; B Chesebro
Journal:  Science       Date:  1986-11-07       Impact factor: 47.728

10.  Infection of mice with lactate dehydrogenase-elevating virus leads to stimulation of autoantibodies.

Authors:  W A Cafruny; D E Hovinen
Journal:  J Gen Virol       Date:  1988-03       Impact factor: 3.891

View more
  26 in total

1.  Innate retroviral restriction by Apobec3 promotes antibody affinity maturation in vivo.

Authors:  Mario L Santiago; Robert L Benitez; Mauricio Montano; Kim J Hasenkrug; Warner C Greene
Journal:  J Immunol       Date:  2010-06-21       Impact factor: 5.422

2.  Poliomyelitis in MuLV-infected ICR-SCID mice after injection of basement membrane matrix contaminated with lactate dehydrogenase-elevating virus.

Authors:  Jodi A Carlson Scholz; Rohit Garg; Susan R Compton; Heather G Allore; Caroline J Zeiss; Edward M Uchio
Journal:  Comp Med       Date:  2011-10       Impact factor: 0.982

3.  B cells and TCR avidity determine distinct functions of CD4+ T cells in retroviral infection.

Authors:  Mickaël J-Y Ploquin; Urszula Eksmond; George Kassiotis
Journal:  J Immunol       Date:  2011-08-12       Impact factor: 5.422

4.  Race between retroviral spread and CD4+ T-cell response determines the outcome of acute Friend virus infection.

Authors:  Rebecca Pike; Andrew Filby; Mickaël J-Y Ploquin; Urszula Eksmond; Rute Marques; Inês Antunes; Kim Hasenkrug; George Kassiotis
Journal:  J Virol       Date:  2009-08-19       Impact factor: 5.103

Review 5.  Humoral immunity in the Friend retrovirus infection model.

Authors:  Kalani Halemano; Michael S Harper; Kejun Guo; Sam X Li; Karl J Heilman; Bradley S Barrett; Mario L Santiago
Journal:  Immunol Res       Date:  2013-03       Impact factor: 2.829

6.  Effects of acute and chronic murine norovirus infections on immune responses and recovery from Friend retrovirus infection.

Authors:  Christoph G Ammann; Ronald J Messer; Kimberly Varvel; Blair L Debuysscher; Rachel A Lacasse; Amelia K Pinto; Kim J Hasenkrug
Journal:  J Virol       Date:  2009-10-07       Impact factor: 5.103

7.  Ribonuclease L is not critical for innate restriction and adaptive immunity against Friend retrovirus infection.

Authors:  Sam X Li; Bradley S Barrett; Michael S Harper; Karl J Heilman; Kalani Halemano; Amanda K Steele; Kejun Guo; Robert H Silverman; Mario L Santiago
Journal:  Virology       Date:  2013-05-29       Impact factor: 3.616

8.  Reassessment of murine APOBEC1 as a retrovirus restriction factor in vivo.

Authors:  Bradley S Barrett; Kejun Guo; Michael S Harper; Sam X Li; Karl J Heilman; Nicholas O Davidson; Mario L Santiago
Journal:  Virology       Date:  2014-10-07       Impact factor: 3.616

9.  Negative impact of IFN-γ on early host immune responses to retroviral infection.

Authors:  Amanda K Duley; Mickaël J-Y Ploquin; Urszula Eksmond; Christoph G Ammann; Ronald J Messer; Lara Myers; Kim J Hasenkrug; George Kassiotis
Journal:  J Immunol       Date:  2012-07-20       Impact factor: 5.422

10.  Generalized immune activation as a direct result of activated CD4+ T cell killing.

Authors:  Rute Marques; Adam Williams; Urszula Eksmond; Andy Wullaert; Nigel Killeen; Manolis Pasparakis; Dimitris Kioussis; George Kassiotis
Journal:  J Biol       Date:  2009
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.